Kazia Therapeutics Ltd


By |


Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The company has three technologies - PI3K inhibitors, superbenzopyran, and anti-tropomyosin. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; Trilexium, has a potential application across a range of different cancer types.

Contact Information

Website: www.novogen.com
Email: investment.consultant@novogen.com
Main Phone: +61 294724101
Address: 300 Barangaroo Avenue
Address 2: Level 24
State: NSW
City / Town: Sydney
Country: AUS
Postal Code: 2000

Issuer Information

Exchange: GREY
CEO: James Garner
Employees: 5
$ 0.0351 $ 0. (0.00%)
Last Price 0.0351 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.0351
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 1.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 48,409,621.00 EPS (TTM) -0.09 PE Ratio N/A Exchange Greys